ConductScience.org, home

Paper76165

Effect of histamine H2-receptor antagonists on delayed hypersensitivity.

Avella J and 3 others. Lancet, 1978. Cited by 222 papers, by iCite.

Cite this record

ConductScience Library. Effect of histamine H2-receptor antagonists on delayed hypersensitivity. Papers, record 76165. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/76165

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of histamine H2-receptor antagonists on delayed hypersensitivity.
PubMed
Journal
Lancet
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
222
iCite
Relative citation ratio, by iCite
9.73
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Avella JJ
2Madsen JEJ E
3Binder HJH J
4Askenase PWP W

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CimetidineMajor topic
Drug HypersensitivityMajor topic
ErythemaMajor topic
GuanidinesMajor topic
Hypersensitivity, DelayedMajor topic
Duodenal Ulcer
Female
Humans
Male
Skin
Time Factors

Source PubMed

Download CSV of topics

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 222 citations.

PMIDTitleJournalYearIn PapersSource
33849573H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?Clin Mol Allergy2021https://conductscience.org/library/papers/33849573PubMed
18475336Candida esophagitis in an immunocompetent pregnant woman.Infect Dis Obstet Gynecol1993https://conductscience.org/library/papers/18475336PubMed
16162264Without nerves, immunology remains incomplete -in vivo veritas.Immunology2005https://conductscience.org/library/papers/16162264PubMed
11219486Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists.Drug Saf2001https://conductscience.org/library/papers/11219486PubMed
11015298Histamine H(2) receptors mediate the inhibitory effect of histamine on human eosinophil degranulation.Br J Pharmacol2000https://conductscience.org/library/papers/11015298PubMed
8102968Influence of histamine receptor antagonists on the dynamics of the cutaneous hypersensitivity reaction in patients infected with schistosoma haematobium.Eur J Clin Pharmacol1993https://conductscience.org/library/papers/8102968PubMed
7460719Chronic protracted diarrhea and jejunal atrophy in an infant. Cimetidine-associated stimulation of jejunal mucosal growth.Dig Dis Sci1981https://conductscience.org/library/papers/7460719PubMed
7267508Hyperinfection syndrome with Strongyloides stercoralis.Postgrad Med J1981https://conductscience.org/library/papers/7267508PubMed
7249945Adverse effects of anti-ulcer drugs.Drugs1981https://conductscience.org/library/papers/7249945PubMed
6993076Cimetidine does not accelerate skin graft rejection in mice.Clin Exp Immunol1980https://conductscience.org/library/papers/6993076PubMed
6984638Immunological studies in patients with alopecia receiving dinitrochlorobenzene and cimetidine therapy.Arch Dermatol Res1982https://conductscience.org/library/papers/6984638PubMed
6979447Peripheral blood T lymphocytes in patients with duodenal ulcers treated with cimetidine.Clin Exp Immunol1982https://conductscience.org/library/papers/6979447PubMed
6848450The effect of cimetidine on antibody synthesis in vitro and in vivo.Immunology1983https://conductscience.org/library/papers/6848450PubMed
6716911Immunostimulation. Clinical and experimental perspectives.Klin Wochenschr1984https://conductscience.org/library/papers/6716911PubMed
6363279The role of complement in the induction and regulation of immune responses.Immunology1984https://conductscience.org/library/papers/6363279PubMed
6315585Coordinated therapeutic effects of immune modulators and interferon.Infect Immun1983https://conductscience.org/library/papers/6315585PubMed
6240928Effects of the H2-receptor agonist dimaprit on lymphocyte responsiveness in vitro.Agents Actions1984https://conductscience.org/library/papers/6240928PubMed
6203843The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.Infection1984https://conductscience.org/library/papers/6203843PubMed
6166496Cimetidine prevents the induction of unresponsiveness by feeding T-dependent antigens.Experientia1981https://conductscience.org/library/papers/6166496PubMed
6128216Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.Drugs1982https://conductscience.org/library/papers/6128216PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/76165

GET https://conductscience.org/api/papers/v1/76165/cited_by?page=2